Yifan Zhou
National Institutes of Health
5 Papers
11 Citations
Yifan Zhou is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Transplantation & Cas9. The author has an hindex of 2, co-authored 5 publications. Previous affiliations of Yifan Zhou include Wellcome Trust Sanger Institute.
Chat about Author
Papers
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques
Aisha A. AlJanahi,Aisha A. AlJanahi,Cicera R. Lazzarotto,Shirley Chen,Tae-Hoon Shin,Stefan Cordes,Xing Fan,Isabel Jabara,Yifan Zhou,David J. Young,Byung-Chul Lee,Kyung-Rok Yu,Kyung-Rok Yu,Yuesheng Li,Bradley Toms,Ilker Tunc,So Gun Hong,Lauren L. Truitt,Julia Klermund,Geoffroy Andrieux,Miriam Y. Kim,Toni Cathomen,Saar Gill,Shengdar Q. Tsai,Cynthia E. Dunbar +24 more
TL;DR: In this paper, the authors compared the predictive values of CIRCLE-seq, an in-vitro off-target prediction method, with in-silico prediction (ISP) based solely on genomic sequence comparisons.
18
Macaque CRISPR/Cas9 Age-Related Clonal Hematopoiesis Model Demonstrates Expansion of TET2-Mutated Clones and Applicability for Testing Mitigation Approaches
Tae-Hoon Shin,Shirley Chen,Stefan Cordes,Yifan Zhou,Byung-Chul Lee,Aisha A. AlJanahi,So Gun Hong,Robert E. Donahue,Kyung-Rok Yu,Cynthia E. Dunbar +9 more
TL;DR: A rhesus macaque model of human ARCH utilizing CRISPR/Cas9 technology and RNA-seq indicated that TET2-disrupted myeloid colony-forming units (CFUs) and mature cells exhibited a distinct hyperinflammatory gene expression profile, suggesting that other intrinsic and/or extrinsic factors can regulate the pace of Tet2 clonal expansion.
2
Validation and Long-Term Follow Up of CD33 Off-Targets Predicted In Vitro and In Silico Using Error-Corrected Sequencing in Rhesus Macaques
Aisha A. AlJanahi,Cicera R. Lazzarotto,Shirley Chen,Tae-Hoon Shin,Stefan Cordes,Isabel Jabara,Yifan Zhou,David J. Young,Byung-Chul Lee,Kyung-Rok Yu,Yuesheng Li,Bradley Toms,Ilker Tunc,So Gun Hong,Lauren L. Truitt,Julia Klermund,Miriam Y. Kim,Toni Cathomen,Saar Gill,Shengdar Q. Tsai,Cynthia E. Dunbar +20 more
TL;DR: A rhesus macaque model is utilized to ask whether CIRCLE-Seq (CS), an in vitro off- target prediction method, more accurately identifies off-targets compared to in silico prediction (ISP) based solely on genomic sequence comparisons, and whether a combination of careful gRNA design, followed by screening for predicted off-target sites in target cells by multiple methods may be required for optimizing safety of clinical development.
1
Clonal tracking of erythropoiesis in rhesus macaques
Xing Fan,Chuanfeng Wu,Lauren L. Truitt,Diego A. Espinoza,Stephanie Sellers,Aylin C. Bonifacino,Yifan Zhou,Stefan Cordes,Allen E. Krouse,Mark E. Metzger,Robert E. Donahue,Rong Lu,Cynthia E. Dunbar +12 more
TL;DR: Overall, in this nonhuman primate model with great relevance to human hematopoiesis, this work documented continuous production of erythroid cells from multipotent, non-biased hematoietic stem cell clones at steady-state or under stress.
CRISPR/Cas9 PIG-A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.
Tae Hoon Shin,Eun Jung Baek,Eun Jung Baek,Marcus A.F. Corat,Marcus A.F. Corat,Shirley Chen,Jean-Yves Metais,Jean-Yves Metais,Aisha A. AlJanahi,Yifan Zhou,Robert E. Donahue,Kyung-Rok Yu,Kyung-Rok Yu,Cynthia E. Dunbar +13 more
TL;DR: This work adapted CRISPR/Cas9 editing of T cells for precise genome editing at a site of interest and has accelerated human disease modeling and the development of corrective gene therapies for various genetic disorders.